Format

Send to

Choose Destination
Trends Endocrinol Metab. 2008 Dec;19(10):371-9. doi: 10.1016/j.tem.2008.08.005. Epub 2008 Oct 17.

Insulin resistance, inflammation, and non-alcoholic fatty liver disease.

Author information

1
Department of Medicine, Christian Doppler Research Laboratory for Gut Inflammation, Medical University Innsbruck, Austria. herbert.tilg@i-med.ac.at

Abstract

Non-alcoholic fatty liver disease (NAFLD), the major cause of abnormal liver function in the western world, is often associated with obesity and diabetes. In obese individuals, fat accumulation in the abdominal region affects both lipid and glucose metabolism, and a liver loaded with fat is insulin resistant. Insulin resistance (IR) is often associated with chronic low-grade inflammation, and numerous mediators released from immune cells and adipocytes contribute to development of IR. Recent results showing an important role for these mediators in NAFLD are providing us with a better understanding of this highly prevalent disease with implications for novel therapy development. This review highlights new aspects in development of liver steatosis and the relevance of various cytokines and adipocytokines in NAFLD.

PMID:
18929493
DOI:
10.1016/j.tem.2008.08.005
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center